metoclopramide has been researched along with Dysarthosis in 2 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sandyk, R | 1 |
| Walsh, TD | 1 |
2 other studies available for metoclopramide and Dysarthosis
| Article | Year |
|---|---|
Metoclopramide-induced dysarthria.
Topics: Aged; Dysarthria; Female; Humans; Metoclopramide; Middle Aged; Speech Disorders | 1983 |
Chronic dysarthria and metoclopramide.
Topics: Adult; Dysarthria; Female; Humans; Metoclopramide; Speech Disorders | 1982 |